Breast Cancer Trial, By Invitation NCT06943313 Sponsor: Fudan University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT06943313
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • The person must voluntarily sign a consent form agreeing to take part.
  • The person must be 18 years of age or older.
  • The person must have breast cancer that has either been confirmed through a tissue test or is strongly suspected based on standard imaging scans.
  • The person's doctor must estimate that they have a life expectancy of more than 3 months.
  • The person must agree to use reliable contraception for at least 28 days after the PET/CT scan.
  • The person must be willing and able to follow all the steps outlined in the study plan.
  • The person must not have had surgery to remove the tumour or affected tissue.
  • The person must have had genetic testing done at the Precision Oncology Center of Fudan University Shanghai Cancer Center, and the results must show a specific change in one of three genes or biological pathways (called PIK3CA mutation, PTEN mutation, or increased activity of the PI3K-AKT-mTOR pathway).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant or breastfeeding.
  • People who are unable to lie still on the PET/CT scanner bed during the scan, or who cannot tolerate PET imaging.
  • People who have taken part in another interventional clinical trial within the 1 month before the screening visit.
  • People who are considered likely to be lost to follow-up (meaning they may not be able to be contacted or tracked throughout the study).
  • People who have any other condition that, in the study doctor's opinion, could interfere with the study or make participation unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 April 2025
Est. completion
31 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Standard uptake value

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov